Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
Clinical trial NCT03954236 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03954236
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2027-02-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.